vs
DAKTRONICS INC（DAKT）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
DAKTRONICS INC的季度营收约是Ultragenyx Pharmaceutical Inc.的1.1倍（$229.3M vs $207.3M），DAKTRONICS INC净利率更高（7.6% vs -62.0%，领先69.6%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 10.0%），DAKTRONICS INC自由现金流更多（$14.0M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 16.0%）
达科电子是一家总部位于美国南达科他州布鲁金斯的企业，由两名南达科他州立大学教授于1968年创立，主营业务涵盖视频显示屏、记分牌、数字广告牌、动态信息标识、音响系统及相关产品的设计、生产、销售与服务。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
DAKT vs RARE — 直观对比
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $229.3M | $207.3M |
| 净利润 | $17.5M | $-128.6M |
| 毛利率 | 27.0% | — |
| 营业利润率 | 9.4% | -54.7% |
| 净利率 | 7.6% | -62.0% |
| 营收同比 | 10.0% | 25.9% |
| 净利润同比 | -18.3% | 3.5% |
| 每股收益（稀释后） | $0.35 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $229.3M | $207.3M | ||
| Q3 25 | $219.0M | $159.9M | ||
| Q2 25 | $172.6M | $166.5M | ||
| Q1 25 | $149.5M | $139.3M | ||
| Q4 24 | $208.3M | $164.6M | ||
| Q3 24 | $226.1M | $139.5M | ||
| Q2 24 | $215.9M | $147.0M | ||
| Q1 24 | $170.3M | $108.8M |
| Q4 25 | $17.5M | $-128.6M | ||
| Q3 25 | $16.5M | $-180.4M | ||
| Q2 25 | $-9.4M | $-115.0M | ||
| Q1 25 | $-17.2M | $-151.1M | ||
| Q4 24 | $21.4M | $-133.2M | ||
| Q3 24 | $-4.9M | $-133.5M | ||
| Q2 24 | $2.5M | $-131.6M | ||
| Q1 24 | $10.7M | $-170.7M |
| Q4 25 | 27.0% | — | ||
| Q3 25 | 29.7% | — | ||
| Q2 25 | 25.0% | — | ||
| Q1 25 | 24.6% | — | ||
| Q4 24 | 26.8% | — | ||
| Q3 24 | 26.4% | — | ||
| Q2 24 | 25.7% | — | ||
| Q1 24 | 24.5% | — |
| Q4 25 | 9.4% | -54.7% | ||
| Q3 25 | 10.6% | -106.9% | ||
| Q2 25 | -1.0% | -64.8% | ||
| Q1 25 | -2.4% | -102.6% | ||
| Q4 24 | 7.6% | -74.3% | ||
| Q3 24 | 10.0% | -94.6% | ||
| Q2 24 | 9.0% | -79.1% | ||
| Q1 24 | 4.7% | -151.9% |
| Q4 25 | 7.6% | -62.0% | ||
| Q3 25 | 7.5% | -112.8% | ||
| Q2 25 | -5.5% | -69.0% | ||
| Q1 25 | -11.5% | -108.5% | ||
| Q4 24 | 10.3% | -80.9% | ||
| Q3 24 | -2.2% | -95.7% | ||
| Q2 24 | 1.2% | -89.5% | ||
| Q1 24 | 6.3% | -156.8% |
| Q4 25 | $0.35 | $-1.28 | ||
| Q3 25 | $0.33 | $-1.81 | ||
| Q2 25 | $0.04 | $-1.17 | ||
| Q1 25 | $-0.36 | $-1.57 | ||
| Q4 24 | $0.22 | $-1.34 | ||
| Q3 24 | $-0.11 | $-1.40 | ||
| Q2 24 | $0.18 | $-1.52 | ||
| Q1 24 | $0.09 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $149.6M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $297.5M | $-80.0M |
| 总资产 | $548.4M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $149.6M | $421.0M | ||
| Q3 25 | $136.9M | $202.5M | ||
| Q2 25 | $127.5M | $176.3M | ||
| Q1 25 | $132.2M | $127.1M | ||
| Q4 24 | $134.4M | $174.0M | ||
| Q3 24 | $96.8M | $150.6M | ||
| Q2 24 | $81.3M | $480.7M | ||
| Q1 24 | $76.8M | $112.3M |
| Q4 25 | $297.5M | $-80.0M | ||
| Q3 25 | $279.8M | $9.2M | ||
| Q2 25 | $271.9M | $151.3M | ||
| Q1 25 | $272.3M | $144.2M | ||
| Q4 24 | $260.9M | $255.0M | ||
| Q3 24 | $238.2M | $346.8M | ||
| Q2 24 | $238.8M | $432.4M | ||
| Q1 24 | $236.2M | $140.3M |
| Q4 25 | $548.4M | $1.5B | ||
| Q3 25 | $545.6M | $1.2B | ||
| Q2 25 | $502.9M | $1.3B | ||
| Q1 25 | $524.2M | $1.3B | ||
| Q4 24 | $551.9M | $1.5B | ||
| Q3 24 | $553.9M | $1.5B | ||
| Q2 24 | $527.9M | $1.6B | ||
| Q1 24 | $499.2M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $16.5M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $14.0M | $-100.8M |
| 自由现金流率自由现金流/营收 | 6.1% | -48.6% |
| 资本支出强度资本支出/营收 | 1.1% | 0.5% |
| 现金转化率经营现金流/净利润 | 0.94× | — |
| 过去12个月自由现金流最近4个季度 | $61.7M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $16.5M | $-99.8M | ||
| Q3 25 | $26.1M | $-91.4M | ||
| Q2 25 | $22.9M | $-108.3M | ||
| Q1 25 | $12.0M | $-166.5M | ||
| Q4 24 | $43.3M | $-79.3M | ||
| Q3 24 | $19.5M | $-67.0M | ||
| Q2 24 | $9.5M | $-77.0M | ||
| Q1 24 | $9.5M | $-190.7M |
| Q4 25 | $14.0M | $-100.8M | ||
| Q3 25 | $21.8M | $-92.7M | ||
| Q2 25 | $18.0M | $-110.7M | ||
| Q1 25 | $7.8M | $-167.8M | ||
| Q4 24 | $38.0M | $-79.5M | ||
| Q3 24 | $14.4M | $-68.6M | ||
| Q2 24 | $6.1M | $-79.0M | ||
| Q1 24 | $5.1M | $-193.9M |
| Q4 25 | 6.1% | -48.6% | ||
| Q3 25 | 10.0% | -58.0% | ||
| Q2 25 | 10.5% | -66.5% | ||
| Q1 25 | 5.2% | -120.5% | ||
| Q4 24 | 18.2% | -48.3% | ||
| Q3 24 | 6.4% | -49.2% | ||
| Q2 24 | 2.8% | -53.7% | ||
| Q1 24 | 3.0% | -178.2% |
| Q4 25 | 1.1% | 0.5% | ||
| Q3 25 | 2.0% | 0.8% | ||
| Q2 25 | 2.8% | 1.5% | ||
| Q1 25 | 2.8% | 1.0% | ||
| Q4 24 | 2.6% | 0.1% | ||
| Q3 24 | 2.2% | 1.2% | ||
| Q2 24 | 1.6% | 1.4% | ||
| Q1 24 | 2.6% | 3.0% |
| Q4 25 | 0.94× | — | ||
| Q3 25 | 1.58× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.02× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.75× | — | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DAKT
| Live Events Segment | $81.5M | 36% |
| Transferred At Point In Time | $41.9M | 18% |
| Limited Configuration | $39.2M | 17% |
| Other | $30.6M | 13% |
| Transportation Segment | $21.3M | 9% |
| Transferred Over Time | $8.8M | 4% |
| Unique Configuration | $6.0M | 3% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
